Loading clinical trials...
Loading clinical trials...
Neuromodulation and Cognitive Behavioral Therapy for Insomnia in MCI
The goal of this study is to test a new way to improve sleep quality in persons living with mild cognitive impairment. The treatment combines a safe and gentle way to stimulate the brain, called transcranial magnetic stimulation, with a psychological treatment, called cognitive behavioral therapy for insomnia.
Age
60 - No limit years
Sex
ALL
Healthy Volunteers
No
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Start Date
May 1, 2025
Primary Completion Date
June 30, 2028
Completion Date
June 30, 2028
Last Updated
October 24, 2025
30
ESTIMATED participants
Transcranial Magnetic Stimulation (TMS) therapy
DEVICE
Cognitive behavioral therapy for insomnia (CBT-I)
BEHAVIORAL
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborators
NCT06032377
NCT06181643
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06807086